tyrosine has been researched along with MODS in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 12 (63.16) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bramanti, P; Cuzzocrea, S; Di Paola, R; Galuppo, M; Mazzon, E; Paterniti, I | 1 |
| Bramanti, P; Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Mazzon, E | 1 |
| Aloisi, C; Cuzzocrea, S; Galuppo, M; Italiano, D; Mazzon, E; Mondello, P; Mondello, S | 1 |
| Barbera, A; Caputi, AP; Centorrino, T; Chatterjee, PK; Ciccolo, A; Cuzzocrea, S; Dugo, L; Fulia, F; Mazzon, E; McDonald, MC; Serraino, I; Thiemermann, C | 1 |
| Cuzzocrea, S; Izumi, M; McDonald, MC; Thiemermann, C | 1 |
| Caputi, AP; Chatterjee, PK; Cuzzocrea, E; Cuzzocrea, S; Di Paola, R; Fulia, F; Genovese, T; Ianaro, A; Patel, NS; Pisano, B; Rossi, A; Sautebin, L; Thiemermann, C | 1 |
| Caputi, AP; Cuzzocrea, S; De Angelis, A; Filippelli, A; Imperatore, F; Liguori, G; Luongo, C; Rossi, F; Scafuro, A | 1 |
| Cuzzocrea, S; Di Paola, R; Esposito, E; Macarthur, H; Matuschak, GM; Mazzon, E; Salvemini, D | 1 |
| Crisafulli, C; Cuzzocrea, S; Di Paola, R; Esposito, E; Genovese, T; Malleo, G; Mazzon, E; Meli, R; Muià, C; Sessa, E | 1 |
| Eiselt, M; Kohoutková, L; Lacigová, S; Novák, I; Opatrný, K; Pittrová, H; Rusavý, P; Srámek, V; Veselá, E | 1 |
| Caputi, AP; Ciriaco, E; Costantino, G; Cuzzocrea, S; de Sarro, A; de Sarro, G; Laurà, R; Mazzon, E | 1 |
| Cuzzocrea, S; McDonald, MC; Mota-Filipe, H; Thiemermann, C | 1 |
| Caputi, AP; Costantino, G; Cuzzocrea, S; Filippelli, A; Imperatore, F; Luongo, C; Mangoni, G; Mazzon, E; Rossi, F; Scafuro, MA | 1 |
| Bauer, JA; Crouser, ED; Fahy, RJ; Julian, MW; Weinstein, DM | 1 |
| Cuzzocrea, S; Foster, SJ; Olbrich, A; Thiemermann, C; Zacharowski, K | 1 |
| Fukuyama, N; Halejcio-Delophont, P; Hoshiai, K; Nakazawa, H | 1 |
| Caputi, AP; Centorrino, T; Ciccolo, A; Cuzzocrea, S; Filipe, HM; Lepore, V; Mazzon, E; McDonald, MC; Terranova, ML; Thiemermann, C | 1 |
| Barbera, A; Caputi, AP; Centorrino, T; Ciccolo, A; Cuzzocrea, S; Dugo, L; Fonti, MT; Mazzon, E | 1 |
| Belzberg, H; Coleman, B; Pittiruti, M; Placko, R; Sganga, G; Siegel, JH; Wedel, S; Wiles, CE | 1 |
1 trial(s) available for tyrosine and MODS
| Article | Year |
|---|---|
Glutamine and other amino acid losses during continuous venovenous hemodiafiltration.
Topics: Acute Kidney Injury; Adult; Aged; Amino Acids; Female; Glutamine; Hemodiafiltration; Humans; Isoleucine; Leucine; Lysine; Male; Methionine; Middle Aged; Multiple Organ Failure; Parenteral Nutrition, Total; Phenylalanine; Reference Standards; Tyrosine; Valine | 1997 |
18 other study(ies) available for tyrosine and MODS
| Article | Year |
|---|---|
PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice.
Topics: Acute Disease; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Adhesion Molecules; Cytokines; Fas Ligand Protein; Flavonoids; I-kappa B Proteins; Inflammation Mediators; Male; Mice; Mitogen-Activated Protein Kinases; Multiple Organ Failure; Neutrophil Infiltration; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Peritonitis; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Systemic Inflammatory Response Syndrome; Time Factors; Transcription Factor RelA; Tyrosine; Zymosan | 2010 |
Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice.
Topics: Alanine Transaminase; Alkaline Phosphatase; Amylases; Animals; Apoptosis; Ascitic Fluid; Aspartate Aminotransferases; bcl-2-Associated X Protein; Bicarbonates; Bilirubin; Blood Gas Analysis; Body Weight; Cell Count; Creatinine; Fas Ligand Protein; Hydrogen-Ion Concentration; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-1beta; Kidney; Lipase; Liver; Lung; Male; Mice; Mice, Inbred Strains; Multiple Organ Failure; Nitrates; Nitrites; P-Selectin; Pancreas; Phosphodiesterase 3 Inhibitors; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Pyridones; Survival Analysis; Tumor Necrosis Factor-alpha; Tyrosine; Zymosan | 2011 |
Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Body Weight; Cytokines; Enzyme Activation; Fas Ligand Protein; Gene Expression Regulation; Glutamine; Inflammation; Lipid Peroxidation; Male; Mice; Multiple Organ Failure; Neutrophil Infiltration; Nitric Oxide; Peritoneal Cavity; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerases; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Tyrosine; Zymosan | 2011 |
Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat.
Topics: Animals; Calpain; Cell Movement; Cyclooxygenase 2; Dose-Response Relationship, Drug; Glycoproteins; Immunohistochemistry; Intestinal Mucosa; Intestines; Isoenzymes; Liver; Lung; Male; Malondialdehyde; Multiple Organ Failure; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peritoneum; Peritonitis; Peroxidase; Peroxynitrous Acid; Poly Adenosine Diphosphate Ribose; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Tyrosine; Zymosan | 2002 |
A novel, potent and selective inhibitor of the activity of inducible nitric oxide synthase (GW274150) reduces the organ injury in hemorrhagic shock.
Topics: Animals; Blood Pressure; Enzyme Inhibitors; Heart Rate; Liver; Lung; Male; Multiple Organ Failure; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Shock, Hemorrhagic; Sulfides; Tyrosine | 2002 |
Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice.
Topics: Animals; Antioxidants; Blotting, Western; Chemotaxis, Leukocyte; Disease Models, Animal; Drug Evaluation, Preclinical; Immunohistochemistry; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred Strains; Multiple Organ Failure; Neutrophils; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxidase; Poly(ADP-ribose) Polymerases; Pyrrolidines; Random Allocation; Thiocarbamates; Time Factors; Tyrosine; Zymosan | 2003 |
Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome.
Topics: Analysis of Variance; Animals; Aorta; Endothelium, Vascular; Hyperbaric Oxygenation; Immunohistochemistry; Male; Malondialdehyde; Multiple Organ Failure; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Random Allocation; Rats; Rats, Sprague-Dawley; Tyrosine; Vascular Diseases; Vasodilation; Zymosan | 2004 |
A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock.
Topics: Amidines; Animals; Benzylamines; Endothelium, Vascular; Liver; Male; Metalloporphyrins; Multiple Organ Failure; Nitric Oxide; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Shock, Septic; Tyrosine; Vasoconstriction | 2006 |
Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan.
Topics: Animals; Apoptosis; Fas Ligand Protein; Inflammation; Intestines; Kidney; Lipid Peroxidation; Mice; Mice, Knockout; Multiple Organ Failure; Neutrophil Infiltration; Nitric Oxide; PPAR alpha; Shock; Tumor Necrosis Factor-alpha; Tyrosine; Up-Regulation; Zymosan | 2006 |
Role of interleukin-6 in a non-septic shock model induced by zymosan.
Topics: Animals; Antibodies, Monoclonal; Ascites; Ascitic Fluid; DNA Damage; Energy Metabolism; Injections, Intraperitoneal; Interleukin-6; Intestine, Small; Leukocyte Count; Lipid Peroxidation; Liver; Lung; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Organ Failure; NAD; Neutrophils; Nitrates; Nitrites; Oxidative Phosphorylation; Peritonitis; Peroxidase; Shock; Tyrosine; Zymosan | 1999 |
A membrane-permeable radical scavenger reduces the organ injury in hemorrhagic shock.
Topics: Animals; Cell Membrane Permeability; Cyclic N-Oxides; Free Radical Scavengers; Intestinal Mucosa; Intestines; Kidney; Liver; Lung; Male; Multiple Organ Failure; Rats; Rats, Wistar; Reactive Oxygen Species; Resuscitation; Shock, Hemorrhagic; Spin Labels; Tyrosine | 1999 |
Role of hyperbaric oxygen exposure in reduction of lipid peroxidation and in multiple organ failure induced by zymosan administration in the rat.
Topics: Animals; Hyperbaric Oxygenation; Lipid Peroxidation; Male; Malondialdehyde; Multiple Organ Failure; Peritonitis; Peroxidase; Rats; Rats, Sprague-Dawley; Tyrosine; Zymosan | 2000 |
Endotoxin-induced ileal mucosal injury and nitric oxide dysregulation are temporally dissociated.
Topics: Animals; Apoptosis; Cats; Ileum; Immunohistochemistry; Intestinal Mucosa; Lipopolysaccharides; Male; Mitochondria; Multiple Organ Failure; Necrosis; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxygen Consumption; Sepsis; Tyrosine | 2000 |
Membrane-permeable radical scavenger, tempol, reduces multiple organ injury in a rodent model of gram-positive shock.
Topics: Animals; Blood Pressure; Cyclic N-Oxides; Free Radical Scavengers; Kidney; Lipopolysaccharides; Liver; Lung; Male; Multiple Organ Failure; Multiple Trauma; Nitrates; Nitrites; Peptidoglycan; Random Allocation; Rats; Rats, Wistar; Shock, Septic; Spin Labels; Staphylococcal Infections; Teichoic Acids; Tyrosine | 2000 |
No evidence of NO-induced damage in potential donor organs after brain death.
Topics: Animals; Biomarkers; Brain Death; Chromatography, High Pressure Liquid; Heart Transplantation; Hemodynamics; Lipid Peroxidation; Liver; Liver Transplantation; Male; Multiple Organ Failure; Myocardium; Nitrates; Nitric Oxide; Nitrites; Rats; Rats, Wistar; Thiobarbiturates; Tissue Donors; Tyrosine | 2001 |
Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat.
Topics: Analysis of Variance; Animals; Cyclic N-Oxides; Free Radical Scavengers; In Vitro Techniques; Intestine, Small; Liver; Lung; Male; Multiple Organ Failure; Poly(ADP-ribose) Polymerases; Random Allocation; Rats; Rats, Sprague-Dawley; Spin Labels; Statistics, Nonparametric; Tyrosine; Zymosan | 2001 |
Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan.
Topics: Animals; Enzyme Inhibitors; Exudates and Transudates; Guanidines; Lipid Peroxidation; Liver; Lung; Macrophages, Peritoneal; Male; Mice; Mice, Knockout; Multiple Organ Failure; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Peritonitis; Peroxidase; Poly(ADP-ribose) Polymerases; Rhodamines; Shock; Tyrosine; Zymosan | 2001 |
Increased dependence of leucine in posttraumatic sepsis: leucine/tyrosine clearance ratio as an indicator of hepatic impairment in septic multiple organ failure syndrome.
Topics: Adolescent; Adult; Alanine; Amino Acids; Amino Acids, Essential; Aspartic Acid; Glutamates; Humans; Leucine; Liver; Metabolic Clearance Rate; Multiple Organ Failure; Muscles; Proline; Sepsis; Tyrosine; Wounds and Injuries | 1985 |